home All News open_in_new Full Article

PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus

TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its LaNeo™ MDMA), is pleased to announce that it has filed an amended and restated preliminary short form base shelf prospectus […]


today 2 w. ago attach_file Other

attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Science
attach_file Economics
attach_file Other
attach_file Economics
attach_file Other
attach_file Economics
attach_file Society
attach_file Other


ID: 3767203050
Add Watch Country

arrow_drop_down